Authors: Ishioka, GY Fikes, J Qin, MS Gianfrani, C Chesnut, RW Kahn, LE Streeter, PR Woulfe, SL Sette, A

Citation: Gy. Ishioka et al., Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function, VACCINE, 19(27), 2001, pp. 3710-3719

Authors: Tangri, S Ishioka, GY Huang, XQ Sidney, J Southwood, S Fikes, S Sette, A

Citation: S. Tangri et al., Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide, J EXP MED, 194(6), 2001, pp. 833-846

Authors: Tsunoda, I Sette, A Fujinami, RS Oseroff, C Ruppert, J Dahlberg, C Southwood, S Arrhenius, T Kuang, LQ Kubo, RT Chesnut, RW Ishioka, GY

Citation: I. Tsunoda et al., Lipopeptide particles as the immunologically active component of CTL inducing vaccines, VACCINE, 17(7-8), 1999, pp. 675-685

Authors: Ishioka, GY Fikes, J Hermanson, G Livingston, B Crimi, C Qin, MS del Guercio, MF Oseroff, C Dahlberg, C Alexander, J Chesnut, RW Sette, A

Citation: Gy. Ishioka et al., Utilization of MHC class I transgenic mice for development of minigene DNAvaccines encoding multiple HLA-restricted CTL epitopes, J IMMUNOL, 162(7), 1999, pp. 3915-3925